Vol. 11 No. 3 (2005)

Published: 2005-04-01

Editorial

Editorial: Is the UK NHS a good place to do clinical trials?

Jan Steiner
- PDF

Commentary

Introduction to the debate: How much regulation do we want or need?

Derek Burke
- PDF

Article

NGO war on biotechnology

Henry I Miller, Gregory Conko
- PDF
Plant biotechnology, the regulator and the consumer

Janet Bainbridge
- PDF
The latest orphan drug designations and the Commission Communication on Regulation (EC) 141/2000

Rashmi R Shah
- PDF
Corporate development in biotechnology in 2005

Alan Williams
- PDF
Distribution of data and unique material resources made with NIH funding

Mark L Rohrbaugh
- PDF
Amgen v TKT: Assessment of inventive concept is crucial for assessing infringement of biotechnology patents

William Cook
- PDF
The quest for generic biotechnology pharmaceuticals in the USA

Thomas J Kowalski, Pamela Fekete, nne-Marie C Yvon
- PDF
The DNA/RNA market to 2010

Mark Belsey, Alex K Pavlou
- PDF

Legal and Regulatory Updates

Legal and regulatory update

John Wilkinson, Frederick J Dorey
- PDF
Financial accounts reports

Colin Aaronson
- PDF